Nanobiotix Sa ADR (NBTX) has released an update.
Nanobiotix, a company at the forefront of developing physics-based cancer treatments, is slated to reveal its first quarter financial and operational results for 2024 on May 22, before the US and EU markets open. This announcement will be accompanied by a conference call and webcast, where the CEO and CFO will discuss the results and business updates. Additionally, the company has scheduled its Annual General Meeting for May 28, 2024, with related materials available on its website.
For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.
